Glenn Nedwin, Ph.D., MBA, Co-Founder And President Of Novozymes, Inc.., To Join Dyadic International, Inc. As Chief Scientific Officer And President Of Its Biosciences Business

JUPITER, Fla.--(BUSINESS WIRE)--March 21, 2006--Dyadic International, Inc. (AMEX:DIL), a biotechnology company, announced today that Glenn E. Nedwin, Ph.D., MBA, co-founder and President since 1991 of Novozymes, Inc., has been appointed to the positions of Chief Scientific Officer, Executive Vice President and President of Dyadic's Biosciences Business effective tomorrow, March 22, 2006. Dr. Nedwin also will join Dyadic's Board of Directors.